<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HC8FFF3A5496A458A956D1CBBEE240D05" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 7253 IH: Clarifying Remanufacturing to Protect Patient Safety Act of 2022</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-03-28</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 7253</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220328">March 28, 2022</action-date><action-desc><sponsor name-id="P000608">Mr. Peters</sponsor> (for himself, <cosponsor name-id="J000302">Mr. Joyce of Pennsylvania</cosponsor>, and <cosponsor name-id="S001216">Ms. Schrier</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to provide for clarification of requirements for the remanufacturing of medical devices, and for other purposes.</official-title></form><legis-body id="H6B2EFFD478E149B8AF0A9F89D7502D0C" style="OLC"><section id="H41F9E37FFFFA40FE8B0AE5E57512766E" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Clarifying Remanufacturing to Protect Patient Safety Act of 2022</short-title></quote>. </text></section><section id="H4E22C039988B4C11B56596A860665754"><enum>2.</enum><header>Clarification of remanufacturing in definition</header><text display-inline="no-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>) is amended—</text><paragraph id="H8843E392A0E64465ABB7943935D910D9"><enum>(1)</enum><text>by subsection (a), by amending paragraph (1) to read as follows:</text><quoted-block style="OLC" id="H0617EFCCFE034CCBA73211D6B194DF03" display-inline="no-display-inline"><paragraph id="H18D115B5D89B4D4696D184DC2686D927"><enum>(1)</enum><text display-inline="yes-display-inline">The term <term>manufacture, preparation, propagation, compounding, or processing</term> shall include the following:</text><subparagraph id="H6F00C01ABCE54166A0DF2B23F0FDE4E4"><enum>(A)</enum><text display-inline="yes-display-inline">Repackaging or otherwise changing the container, wrapper, or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the person who makes final delivery or sale to the ultimate consumer or user.</text></subparagraph><subparagraph id="H693BAD4E14D64AB2824D01A9F26C7EDF"><enum>(B)</enum><text display-inline="yes-display-inline">Remanufacturing of any finished device by engaging in any act that could significantly change the performance or safety specifications, or intended use, of the finished device, including by significantly changing—</text><clause id="HE7EA9ECC5DDA4E3BAF6BDFC7E360A208"><enum>(i)</enum><text>a sterilization method;</text></clause><clause id="H9BB8CF8494774C88829D680E9B2213AE"><enum>(ii)</enum><text>a reprocessing instruction;</text></clause><clause id="HBE0313C5BA8A4C8292C98405A08659BE"><enum>(iii)</enum><text>a control mechanism, operating principle, or energy input or output;</text></clause><clause id="H49E9ECFD9DA54363AD3FDD63823EB071"><enum>(iv)</enum><text>the anatomical location of use; or</text></clause><clause id="HDBAE4D004C6940B08B976902BECB118E"><enum>(v)</enum><text>the design.</text></clause></subparagraph></paragraph><after-quoted-block>; and</after-quoted-block></quoted-block></paragraph><paragraph id="H6B7B0637AC4F486D9A736E0436B1C5D8"><enum>(2)</enum><text>in subsection (j), by adding at the end the following:</text><quoted-block id="H06735960266D4791829AF698248A743B" style="OLC"><paragraph id="H38F8F4A1ED82418E878E5D6707DBA3B9" indent="up1"><enum>(6)</enum><text>The Secretary shall require that lists of devices reported pursuant to paragraph (2) specifically identify in any such list those devices that have been or are being remanufactured as described in subsection (a)(1)(B).</text></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section><section id="H00B5AF5822034039A5FB3782F4DCE5CE"><enum>3.</enum><header>Inspection of device remanufacturing establishments</header><text display-inline="no-display-inline">Section 510(h) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360(h)</external-xref>) is amended—</text><paragraph id="H412CCFA887C74AE4A505412D1A1A7F31" commented="no"><enum>(1)</enum><text>in paragraph (4)—</text><subparagraph id="HB2528F22C9CA4F64AD4AD88641055934"><enum>(A)</enum><text>by redesignating subparagraph (H) as subparagraph (G); and</text></subparagraph><subparagraph id="H48D388FAB4EE4B3EAE318F6B9151D9ED"><enum>(B)</enum><text>by inserting after subparagraph (F) the following:</text><quoted-block style="OLC" id="H4FA71D285515496D8B6E00C1346E2656" display-inline="no-display-inline"><subparagraph id="H39C4D768A2244C0C9B59D48D6D587BD9" commented="no"><enum>(G)</enum><text display-inline="yes-display-inline">Whether the establishment is registered as a remanufacturer or otherwise believed to be engaged in remanufacturing. </text></subparagraph><after-quoted-block>; and </after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="HCB0857E2AAE54AB181CF586A9CE1564C"><enum>(2)</enum><text>in paragraph (6)(A)—</text><subparagraph id="H93E41E8D9A1A4C9195E6330D66DE7F44"><enum>(A)</enum><text>in clause (i), by striking <quote>and</quote> at the end;</text></subparagraph><subparagraph id="H3A18EADB22E0460998D007669CD113DB"><enum>(B)</enum><text display-inline="yes-display-inline">in clause (ii), by inserting <quote>and</quote> after the semicolon; and</text></subparagraph><subparagraph id="HDF5BD2C5D9AF40858C801916AE69855C"><enum>(C)</enum><text>by adding at the end the following:</text><quoted-block style="OLC" id="H5322E00CC12A406DA26ED45E917F9A62" display-inline="no-display-inline"><clause id="H1E1ECE9A256249C38A86E11B165AE628" indent="up1"><enum>(iii)</enum><text display-inline="yes-display-inline">the number of establishments registered as remanufacturers that the Secretary inspected in the previous calendar year;</text></clause><after-quoted-block>.</after-quoted-block></quoted-block></subparagraph></paragraph></section><section id="H7019CC4697C049149F1EC3392921993B"><enum>4.</enum><header>Device remanufacturing public education</header><subsection id="H31D4B21579254E0AA610D34B91FAD489"><enum>(a)</enum><header>In general</header><text>The Secretary of Health and Human Services shall hold at least one public forum within 12 months after the date of enactment of this Act, and shall take other ongoing steps as necessary, to increase public awareness of the requirements applicable to device remanufacturing, including—</text><paragraph id="H60889576D3A44F41A630FA36D074C769"><enum>(1)</enum><text>holding webinars; and</text></paragraph><paragraph id="HC6E3E41B38004930A740DBD8C9B951E2"><enum>(2)</enum><text>engaging in other outreach to regulated industry, professional societies, advocacy groups, State and local governmental entities, and other stakeholders.</text></paragraph></subsection><subsection id="H7ED54C94074B40D7B215849EA0279B75"><enum>(b)</enum><header>Report</header><paragraph id="H02040617C3424B0B905CB8C0F54B93B7"><enum>(1)</enum><header>In general</header><text>Not later than 2 years after the date of enactment of this Act, the Secretary of Health and Human Services shall—</text><subparagraph id="H64BE16DC2E284A3B8F5D53C1EE623867"><enum>(A)</enum><text>prepare and post on the website of the Food and Drug Administration a report with regard to the remanufacturing of devices; and</text></subparagraph><subparagraph id="H14C5F1EB0B49483F952C0009A03B8D1B"><enum>(B)</enum><text display-inline="yes-display-inline">brief the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate regarding the findings of such report.</text></subparagraph></paragraph><paragraph id="HB64F9AD211854FACA85439EFCB9D9BB8"><enum>(2)</enum><header>Contents</header><text>The report under paragraph (1) shall include the following:</text><subparagraph id="H5871876A4F494739BEE6C1E33D223F92"><enum>(A)</enum><text>A description of the activities carried out, and additional activities intended to be carried out, under subsection (a).</text></subparagraph><subparagraph id="H2C1BA65043D24E5EB6F283A836538C45"><enum>(B)</enum><text>The number of remanufacturing establishment registrations and remanufactured device listings under section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>), and any trends in such registrations and listings.</text></subparagraph><subparagraph id="H1CF254AB293E4A55A7A69946E51A276E"><enum>(C)</enum><text display-inline="yes-display-inline">An assessment of whether the Food and Drug Administration should issue guidance for remanufacturers on compliance with the establishment registration and device listing requirements of such section 510.</text></subparagraph><subparagraph id="HF7E62C3499844215BD35927950CE19C5"><enum>(D)</enum><text>A summary of inspections carried out, warning letters and other advisory actions, and enforcement actions relating to remanufacturing establishments since the date of enactment of this Act.</text></subparagraph><subparagraph id="H14C60054A0E545CCB60BBC5262937F9F"><enum>(E)</enum><text>The status of actions undertaken pursuant to the report issued by the Secretary pursuant to section 710 of the FDA Reauthorization Act of 2017 (<external-xref legal-doc="public-law" parsable-cite="pl/115/52">Public Law 115–52</external-xref>).</text></subparagraph></paragraph><paragraph id="HDA5FE957ACAD42D7BB72FE07687E2FA9"><enum>(3)</enum><header>Annual updates</header><text>On an annual basis, the Secretary of Health and Human Services shall—</text><subparagraph id="H73F3A679AE574FEBB7F39AA688BB9E8D"><enum>(A)</enum><text>update the report required by this subsection with regard to the information described in subparagraphs (B) and (D) of paragraph (2); and</text></subparagraph><subparagraph id="H0C1CDE59855F4F2E8D0499E308A00B82"><enum>(B)</enum><text display-inline="yes-display-inline">post each such update on the website of the Food and Drug Administration.</text></subparagraph></paragraph></subsection><subsection id="H78A1FC077BD44A7FA0F96BF70EAAAD71"><enum>(c)</enum><header>Definition</header><text>In this section and section 5, the term <term>device</term> has the meaning given to such term in section 201 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>).</text></subsection></section><section id="H605559FC3D47420494A5015107483D41"><enum>5.</enum><header>Enhanced communications regarding remanufacturing</header><text display-inline="no-display-inline">The Secretary shall implement a process, to be posted on the website of the Food and Drug Administration, to receive through the Food and Drug Administration submissions from State regulatory bodies and other State authorities—</text><paragraph id="HC9C453B300EE413994FDEDA63F1135BA"><enum>(1)</enum><text>expressing concerns that an entity that is remanufacturing devices—</text><subparagraph id="H6CE1AB2636C6417DB23C929851BFEC24"><enum>(A)</enum><text>is not registered under section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>); or</text></subparagraph><subparagraph id="H8F270954A2F74E339A1F009966AEA580"><enum>(B)</enum><text>may otherwise be acting contrary to the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>); and</text></subparagraph></paragraph><paragraph id="HE6D17A3E6F1A477AB901879810142FDF"><enum>(2)</enum><text>describing any actions taken by State authorities against such entity.</text></paragraph></section></legis-body></bill> 

